Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-128
Closed -$3.24K 364
2025
Q1
$3.24K Buy
+128
New +$3.35K ﹤0.01% 320
2024
Q4
Sell
-29,360
Closed -$850K 383
2024
Q3
$850K Buy
29,360
+2,030
+7% +$59.2K 0.04% 158
2024
Q2
$765K Buy
+27,330
New +$752K 0.04% 162

Other funds holding PFE

Aviso Financial's PFE Position: Q2 2025 in Review

Aviso Financial sold out of Pfizer (PFE) in Q2 2025, closing a stake of 128 shares — an estimated $3.24K sold.

Aviso Financial first reported a position in PFE in Q2 2024 and held it in 3 quarters. The position peaked at $850K in Q3 2024. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Aviso Financial reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Aviso Financial sold 128 Pfizer shares in Q2 2025, an estimated $3.24K.
  • Aviso Financial first reported a position in Pfizer in Q2 2024 and held it in 3 quarters.
  • Aviso Financial's Pfizer position peaked at $850K in Q3 2024.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Aviso Financial's 13F filing for Q2 2025, filed 12 Aug 2025.